U.S. HIV/AIDS Therapies Markets

U.S. HIV/AIDS Therapies Markets

 

RELEASE DATE
27-Jan-2003
REGION
North America
Deliverable Type
Market Research
Research Code: A379-01-00-00-00
SKU: HC00871-NA-MR_04612
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC00871-NA-MR_04612

$2,450.00

$1,837.50save 25 %

DownloadLink
ENQUIRE NOW

Description

The U.S. HIV/AIDS Therapies Markets report covers the various antiretroviral (ARV) drugs that are currently available in the U.S. namely, NRTIs, PIs and NNRTIs. The report also covers the pipeline drugs from the existing and novel ARV categories, and the HIV vaccines pipeline. Frost & Sullivan Market Engineering Analysis, major market/technology trends, challenges, drivers and restraints and forecasts are covered on a total level and also as at the levels of the various segments. The report cites three prestigious Frost & Sullivan Market Engineering Awards to active industry participants for effective industry approaches.

Table of Contents

Executive Summary

  • Executive Summary

HIV/AIDS: Definition and Classification

  • Report Scope
  • The Human Immunodeficiency Virus
  • Acquired Immuno-Deficiency Syndrome(AIDS)
  • Etiology and Demography
  • Diagnostic Tests
  • Overview of HIV/AIDS Therapies
  • Highly Active Antiretroviral Therapy(HAART)

Challenges and Strategies

  • Overview of Challenges
  • Challenge 1: Higher Drug Resistance
  • Challenge 2: Inconsistent Patient Adherence
  • Challenge 3: Higher Pill Burdens
  • Challenge 4: Drug-Induced Dyslipidemia
  • Challenge 5: Patients' Lower Tolerability
  • Challenge 6: Limited Funds and High Drug Prices

Market Dynamics

  • Market Drivers
  • Market Restraints
  • Pricing Trends
  • Demand Analysis
  • Revenue Forecasts
  • Market Engineering Analysis

Competitive Analysis

  • Competitive Structure
  • Market Share Analysis

Market Engineering Awards

  • Marketing Strategy Leadership Award
  • Product Innovation Award
  • Business Development Strategy Award

Market Overview

Market Dynamics

Competitive Analysis

Pipeline ARV Drugs in Novel Categories

HIV/AIDS Vaccines

The U.S. HIV/AIDS Therapies Markets report covers the various antiretroviral (ARV) drugs that are currently available in the U.S. namely, NRTIs, PIs and NNRTIs. The report also covers the pipeline drugs from the existing and novel ARV categories, and the HIV vaccines pipeline. Frost & Sullivan Market Engineering Analysis, major market/technology trends, challenges, drivers and restraints and forecasts are covered on a total level and also as at the levels of the various segments. The report cites three prestigious Frost & Sullivan Market Engineering Awards to active industry participants for effective industry approaches.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number A379-01-00-00-00
Is Prebook No